Spotlight Innovation (OTCMKTS:STLT) Trading 1% Higher – Still a Buy?

Spotlight Innovation Inc. (OTCMKTS:STLT)’s stock price traded up 1% during trading on Monday . The company traded as high as $21.13 and last traded at $21.13. 500 shares were traded during trading, The stock had previously closed at $20.93.

Spotlight Innovation Stock Up 1.0%

Spotlight Innovation Company Profile

Spotlight Innovation Inc is a development-stage biopharmaceutical holding company that specializes in acquiring, licensing and advancing novel therapeutic assets in the immuno-oncology and infectious disease arenas. Headquartered in New York, the company seeks to identify under-invested or early-stage biotech opportunities with the potential for significant clinical and commercial value. Since its founding, Spotlight Innovation has assembled a portfolio of assets through strategic licensing agreements and acquisitions designed to accelerate clinical development and maximize shareholder value.

A core focus for Spotlight Innovation is immunotherapy, particularly agents that modulate the lymphocyte activation gene-3 (LAG-3) pathway.